Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency Scientific paper

Main Article Content

Mehlika Dilek Altıntop
Halide Edip Temel
Ahmet Özdemir


Considerable efforts have been directed towards the discovery of selective cyclooxygenase isoxyme 1 (COX-1) inhibitors due to the recent work highlighting the involvement of COX-1 in the pathogenesis of pain, neuro­inf­lammation, cancer and cardiovascular disorders. In this context, this paper aims to describe 2-pyrazolines endowed with selective COX-1 inhibitory potency. An efficient microwave-assisted synthetic method was applied for the prepar­ation of a series of pyrazolines, which were tested for their COX-1 and cyclo­oxy­genase isoxyme 2 (COX-2) inhibitory effects using a colorimetric assay. The cytotoxic properties of the most potent derivatives on NIH/3T3 fibroblast cells were determined using MTT method. 1-(3-Fluorophenyl)-5-(3,4-methyl­en­dioxyphenyl)-3-(2-thienyl)-4,5-dihydro-1H-pyrazole (2g) and 1-(3-bromo­phenyl)-5-(3,4-methylendioxyphenyl)-3-(2-thienyl)-4,5-dihydro-1H-pyrazole (2h) were determined as selective COX-1 inhibitors. According to the in silico data obtained from Schrödinger’s QikProp module, both compounds are estimated to possess favourable oral bioavailability and drug-likeness. This work could be a rational guideline for further modifications at different sites on 2-pyra­zoline motif to bring out a new class of selective COX-1 inhibitors.


Download data is not yet available.


Metrics Loading ...

Article Details

How to Cite
M. D. Altıntop, H. E. Temel, and A. Özdemir, “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency: Scientific paper”, J. Serb. Chem. Soc., vol. 88, no. 4, pp. 355–365, Jan. 2023.
Organic Chemistry

Funding data


T. Schmid, B. Brüne Front. Immunol. 12 (2021) 714042 (https://dx.doi.org/10.3389/fimmu.2021.714042)

L. L. Mazaleuskaya, E. Ricciotti, Adv. Exp. Med. Biol. 1274 (2020) 29 (https://dx.doi.org/10.1007/978-3-030-50621-6_3)

C. S. Williams, M. Mann, R. N. DuBois, Oncogene 18 (1999) 7908 (https://dx.doi.org/10.1038/sj.onc.1203286)

А. Pannunzio, M. Coluccia, Pharmaceuticals 11 (2018) 101 (https://dx.doi.org/10.3390/ph11040101)

V. Sharma, P. Bhatia, O. Alam, M. Javed Naim, F. Nawaz, A. Ahmad Sheikh, M. Jha Bioorg. Chem. 89 (2019) 103007 (https://dx.doi.org/10.1016/j.bioorg.2019.103007)

M. G. Perrone, A. Scilimati, L. Simone, P. Vitale, Curr. Med. Chem. 17 (2010) 3769 (https://dx.doi.org/10.2174/092986710793205408)

E. Caiazzo, A. Ialenti, L. Cicala, C. Vitale, Eur. J. Pharmacol. 848 (2019) 105 (https://dx.doi.org/10.1016/j.ejphar.2019.01.044)

P. Vitale, A. Panella, A. Scilimati, M. G. Perrone, Med. Res. Rev. 36 (2016) 641 (https://dx.doi.org/10.1002/med.21389)

P. Vitale, A. Scilimati, M. G. Perrone, Curr. Med. Chem. 22 (2015) 4271 (https://dx.doi.org/10.2174/0929867322666151029104717)

K. Goto, H. Ochi, Y. Yasunaga, H. Matsuyuki, T. Imayoshi, H. Kusuhara, T. Okumoto, Prostaglandins Other Lipid Mediat. 56 (1998) 245 (https://dx.doi.org/10.1016/s0090-6980(98)00054-9)

J.M. Alex, R. Kumar, J. Enzyme Inhib. Med. Chem. 29 (2014) 427 (https://dx.doi.org/10.3109/14756366.2013.795956)

B. Nehra, S. Rulhania, S. Jaswal, B. Kumar, G. Singh, V. Monga, Eur. J. Med. Chem. 205 (2020) 112666 (https://dx.doi.org/10.1016/j.ejmech.2020.112666)

S. Kumar, S. Bawa, S. Drabu, R. Kumar, H. Gupta, Recent Pat. Anti-Infect. Drug Discov. 4 (2009) 154 (https://dx.doi.org/10.2174/157489109789318569)

M. R. Shaaban, A. S. Mayhoub, A. M. Farag, Expert Opin. Ther. Pat. 22 (2012), 253 (https://dx.doi.org/10.1517/13543776.2012.667403)

А. Marella, R. Ali, T. Alam, R. Saha, O. Tanwar, M. Akhter, M. Shaquiquzzaman, M. M. Mini-Rev. Med. Chem. 13 (2013) 921 (https://dx.doi.org/10.2174/1389557511313060012)

D. Matiadis, M. Sagnou, Int. J. Mol. Sci. 21 (2020) 5507 (https://dx.doi.org/10.3390/ijms21155507)

C. Cusan, G. Spalluto, M. Prato, M. Adams, A. Bodensieck, R. Bauer, A. Tubaro, P. Bernardi, T. Da Ros, Farmaco 60 (2005) 327 (https://dx.doi.org/10.1016/J.FARMAC.2004.09.002)

M. V. R. Reddy, V. K. Billa, V. R. Pallela, M. R. Mallireddigari, R. Boominathan, J.L. Gabriel, E. P. Reddy, Bioorg. Med. Chem. 16 (2008) 3907 (https://dx.doi.org/10.1016/j.bmc.2008.01.047)

R. Fioravanti, A. Bolasco, F. Manna, F. Rossi, F. Orallo, F. Ortuso, S. Alcaro, R. Cirilli, Eur. J. Med. Chem. 45 (2010) 6135 (https://dx.doi.org/10.1016/j.ejmech.2010.10.005)

S. Carradori, D. Secci, A. Bolasco, C. De Monte, M. Yáñez, Arch. Pharm. Chem. Life Sci. 345 (2012) 973 (https://dx.doi.org/10.1002/ardp.201200249)

M. A. El-Sayed, N. I. Abdel-Aziz, A. A. Abdel-Aziz, A. S. El-Azab, K. E. ElTahir, Bioorg. Med. Chem. 20 (2012) 3306 (https://dx.doi.org/10.1016/j.bmc.2012.03.044)

M. Yu, H. Yang, K. Wu, Y. Ji, L. Ju, X. Lu, Bioorg. Med. Chem. 22 (2014) 4109 (https://dx.doi.org/10.1016/j.bmc.2014.05.059)

K. R. A. Abdellatif, M. A. Abdelgawad, M. B. Labib, T. H. Zidan, Bioorg. Med. Chem. Lett. 25 (2015) 5787 (https://dx.doi.org/10.1016/j.bmcl.2015.10.047)

K. R. A. Abdellatif, H. A. H. Elshemy, A. A. Azoz, Bioorg. Chem. 63 (2015) 13 (https://dx.doi.org/10.1016/j.bioorg.2015.09.002)

M. A. Abdel-Sayed, S. M. Bayomi, M. A. El-Sherbeny, N. I. Abdel-Aziz, K. E. ElTahir, G. S. Shehatou, A. A. Abdel-Aziz, Bioorg. Med. Chem. 24 (2016) 2032 (https://dx.doi.org/10.1016/j.bmc.2016.03.032)

K. R. A. Abdellatif, M. T. Elsaady, S. A. Abdel-Aziz, A. H. Abusabaa, J. Enzyme Inhib. Med. Chem. 31 (2016) 1545 (https://dx.doi.org/10.3109/14756366.2016.1158168)

M. Lutz, J. Clin. Pharmacol. 59 (2019) 1433 (https://dx.doi.org/10.1002/jcph.1512)

А. Özdemir, B. Sever, M. D. Altıntop, E. Kaya Tilki, M. Dikmen, Molecules 23 (2018) 2151 (https://dx.doi.org/10.3390/molecules23092151)

А. Özdemir, M. D. Altıntop, Z. A. Kaplancıklı, G. Turan-Zitouni, G. Akalın Çiftçi, Ş. Ulusoylar Yıldırım, J. Enzyme Inhib. Med. Chem. 28 (2013) 1221 (https://dx.doi.org/10.3109/14756366.2012.724682)

T. Mosmann, J. Immunol. Methods 16 (1983) 55 (https://dx.doi.org/10.1016/0022-1759(83)90303-4)

E. Berrino, C. T. Supuran, Expert Opin. Drug Discov. 13 (2018) 861 (https://dx.doi.org/10.1080/17460441.2018.1494721)

T. L. Lambat, P. K. P. G. Chopra, S. H. Mahmood, Curr. Org. Chem. 24 (2020) 2527 (https://dx.doi.org/10.2174/1385272824999200622114919)

M. Henary, C. Kananda, L. Rotolo, B. Savino, E. A. Owens, G. Cravotto, RSC Adv. 10 (2020) 14170 (https://dx.doi.org/10.1039/D0RA01378A)

M. B. Gawande, S. N. Shelke, R. Zboril, R. S. Varma, Acc. Chem. Res. 47 (2014) 1338 (https://dx.doi.org/10.1021/ar400309b)

J. M. Kremsner, A. Stadler, A Chemist’s Guide to Microwave Synthesis, 3rd ed., Anton Paar GmbH, Graz, 2018, p. 300

Y. Wang, J. Xing, Y. Xu, N. Zhou, J. Peng, Z. Xiong, X. Liu, X. Luo, C. Luo, K. Chen, M. Zheng, H. Jiang, Q. Rev. Biophys. 48 (2015) 488 (https://dx.doi.org/10.1017/S0033583515000190)

Schrödinger Release 2022-2, Schrödinger, LLC, New York (https://www.schrodinger.com/)

C. Lohmann, S. Hüwel, H. J. Galla, J. Drug Target. 10 (2002) 263 (https://dx.doi.org/10.1080/10611860290031903)

T. J. Hou, X. J. Xu, J. Chem. Inf. Comput. Sci. 43 (2003) 2137 (https://dx.doi.org/10.1021/ci034134i)

S. Shahbazi, T. R. Sahrawat, M. Ray, S. Dash, D. Kar, S. Singh, PLoS ONE 11 (2016) e0156156 (https://dx.doi.org/10.1371/journal.pone.0156156)

F. Neumaier, B. D. Zlatopolskiy, B. Neumaier, Pharmaceutics 13 (2021) 1542 (https://dx.doi.org/10.3390/pharmaceutics13101542).